LATAVIA WELLS: Open Payments
NPI 1760088272 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,951 in 112 payments from 16 companies in 2025. Trend: 2023 $789 · 2024 $1,921 · 2025 $1,951
Food & beverage: $1,951
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 16 | $243 |
| Otsuka America Pharmaceutical, Inc. | 15 | $195 |
| Teva Pharmaceuticals USA, Inc. | 4 | $168 |
| Vanda Pharmaceuticals Inc. | 6 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $164 |
| Janssen Pharmaceuticals, Inc | 6 | $158 |
| ABBVIE INC. | 9 | $147 |
| Neurocrine BioSciences, Inc. | 4 | $121 |
| Axsome Therapeutics, Inc. | 5 | $116 |
| E.R. Squibb & Sons, L.L.C. | 7 | $115 |
Products named: Qelbree, CAPLYTA, REXULTI, AUSTEDO XR, INVEGA SUSTENNA, VRAYLAR, FANAPT, INGREZZA.
Industry payments across FL — which companies pay providers there.
